3 bad bugs

Nursing

Volumn 40, Issue 3, 2010, Pages 24-30

  Delahanty, Kim ^a   Myers, Frank ^b  

^a UCSD MEDICAL CENTER   (United States)

^b SCRIPPS MERCY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL TOXIN; EXOTOXIN; LEUKOCIDIN; PANTON VALENTINE LEUKOCIDIN; PANTON-VALENTINE LEUKOCIDIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTION; EPIDEMIC; HUMAN; INFECTION CONTROL; INFLUENZA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UNITED STATES;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; EXOTOXINS; HUMANS; INFECTION CONTROL; INFLUENZA, HUMAN; LEUKOCIDINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS; UNITED STATES;

EID: 77249112847     PISSN: 03604039     EISSN: 15388689     Source Type: Journal    
DOI: 10.1097/01.NURSE.0000368813.05100.fb     Document Type: Article

References (25)

1. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359(9308):753-759
2. Wargo KA, Eiland EH. Appropriate antimicrobial therapy for community-acquired methicillinresistant Staphylococcus aureus carrying the Panton Valentine leukocidin genes. Clin Infect Dis. 2005;40(9):1376-1379
3. Gootz TD, Marra A. Acinetobacter baumannii: an emerging multidrug-resistant threat. Expert Rev Anti Infect Ther. 2008;6(3):309-325
4. Centers for Disease Control and Prevention. Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. MMWR Morb Mortal Wkly. 2004;53 (45):1063-1066
5. Manikal VM, Landman D, Saurina G, Oydna E, Lal H, Quale J Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis. 2000;31(1):101-106
6. Villegas MV, Hartstein AI. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol. 2003;24(4):284-295
7. Webster C, Towner KJ, Humphreys H. Survival of Acinetobacter on three clinically related inanimate surfaces. Infect Control Hosp Epidemiol. 2000;21(4):246
8. Griffith ME, Ceremuga JM, Ellis MW, et al. Acinetobacter skin colonization of U.S. Army soldiers. Infect Control Hosp Epidemiol. 2006;27: 659-661
9. Bernards AT, Harinck HI, Dijkshoorn L, van der Reijden TJ, van den Broek Pj. Persistent Acinetobacter baumannii? Look inside your medical equipment. Infect Control Hosp Epidemiol. 2004;25:1002-1004
10. Carling PC, Parry MF, Von Beheren SM. Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals. Infect Control Hosp Epidemiol. 2008;29:1-7
11. Severe Clostridium difficile-associated disease in populations previously at low risk- four states, 2005. MMWR Morb Mortal Wkly. 2005;54(47):1201-1205
12. Eggertson L. Quebec's official numbers: 409 C. difficile deaths. CMAJ. 2005;173(11): 1308. http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC1283487
13. Akerlund T, Persson I, Unemo M, et al. Increased sporulation rate of epidemic Clostridium difficile type 027/NAP1. J Clin Microbiol. 2008;46(4):1530-1533
14. Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med. 2000;342(6):390-397
15. Modena S, Bearelly D, Swartz K, Friedenberg FK. Clostridium difficile among hospitalized patients receiving antibiotics: a case control study. Infect Control Hosp Epidemiol. 2005; 26(8):685-690
16. Malnick SD, Zimhony O. Treatment of Clostridium difficile-associated diarrhea. Ann Pharmacother. 2002;36(11):1767-1775
17. McNulty C, Logan M, Donald IP, et al. Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. J Antimicrob Chemother. 1997;40(5):707-711
18. Sehulster L, Chinn RY. Guidelines for the environmental infection control in healthcare facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR. 2003;RR52 (RR-10):1-42
19. Songer JG, Trinh HT, Killgore GE, Thompson AD, McDonald LC, Limbago BM[W18]. Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis. 2009;15(5): 819-821
20. Faust G, Langelier D, Haddad H, et al. Treatment of recurrent pseudomembranous colitis with stool transplantation: report of six cases. Can J Gastroenterol. 2002;16:A43
21. Aslam S, Hamill R, Musher D. Treatment of Clostridium difficile-associated disease: old therapies and new strategies. Lancet Infect Dis. 2005; 5(9):549-557
22. Kaltsas A. Risk factors and clinical outcomes of ribotype 027 and of non-ribotype 027 strains of C. difficile at an urban hospital. Abstract, 2009 Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology
23. Wilcox MH, Fawley WN, Settle CD, Davidson A. Recurrence of symptoms in Clostridium difficile infection-relapse or reinfection? J Hosp Infect. 1998;38(2):93-100
24. Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of healthcare workers in long-term care hospitals reduces the mortality of elderly patients. J Infect Dis. 1997;175(1): 1-6
25. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of healthcare workers on mortality of elderly people in longterm care: a randomised controlled trial. Lancet. 2000;355(9198):93-97